August - 2021
| Previous Past Months | Showing Journal 6 of 6 |
 Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19The REMAP-CAP, ACTIV-4a, and ATTACC Investigators New Eng J Med, 2021, online August This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules, exam preparation tools, teaching aids and much more, login here, or Become a Member to register |
August |
Previous Comments
No Comments yet.
Comment
Critically ill patients with COVID-19 are at high risk for thrombosis, despite receiving thromboembolism chemoprophylaxis. This is likely due to an environment of raised systemic inflammatory and thrombosis mediators. The use of unfractionated and low molecular weight heparins (UFH and...